323 related articles for article (PubMed ID: 18848872)
1. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
[TBL] [Abstract][Full Text] [Related]
2. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
3. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
[TBL] [Abstract][Full Text] [Related]
4. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
5. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
Sauer D; McGinity J
Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
[TBL] [Abstract][Full Text] [Related]
6. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
Li XN; Guo HX; Heinamaki J
J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
[TBL] [Abstract][Full Text] [Related]
7. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
8. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
Sauer D; McGinity JW
Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
10. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
11. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
Cerea M; Zheng W; Young CR; McGinity JW
Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
[TBL] [Abstract][Full Text] [Related]
12. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
Zheng W; Sauer D; McGinity JW
Eur J Pharm Biopharm; 2005 Jan; 59(1):147-54. PubMed ID: 15567312
[TBL] [Abstract][Full Text] [Related]
13. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
Lai X; Sun C; Tian H; Zhao W; Gao L
Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
[TBL] [Abstract][Full Text] [Related]
16. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
17. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
Terebesi I; Bodmeier R
Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
[TBL] [Abstract][Full Text] [Related]
18. Morphology and surface properties of blends of Eudragit RS with different poly(ethylene glycol)s.
Lovrecich M; Rubessa F
Pharm Dev Technol; 1998 Feb; 3(1):123-9. PubMed ID: 9532607
[TBL] [Abstract][Full Text] [Related]
19. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
Fukuda M; Peppas NA; McGinity JW
J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
[TBL] [Abstract][Full Text] [Related]
20. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
